Ticker Details
Arcutis Biotherapeutics, Inc.
IPO Date:	January 31, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$3.6B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.62 | 3.56%
Avg Daily Range (30 D):	$0.60 | 2.48%
Avg Daily Range (90 D):	$0.62 | 2.63%

Institutional Daily Volume
Avg Daily Volume:	1.16M
Avg Daily Volume (30 D):	1.33M
Avg Daily Volume (90 D):	1.24M

Trade Size
Avg Trade Size (Sh.):	96
Avg Trade Size (Sh.) (30 D):	67
Avg Trade Size (Sh.) (90 D):	66

Institutional Trades
Total Institutional Trades:	2,541
Avg Institutional Trade:	$2.33M
Avg Institutional Trade (30 D):	$4.14M
Avg Institutional Trade (90 D):	$3.58M
Avg Institutional Trade Volume:	.16M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$3.16M
Avg Closing Trade (30 D):	$9.14M
Avg Closing Trade (90 D):	$7.15M
Avg Closing Volume:	210.96K

News

Jun 29, 2026 @ 11:06 PM FDA Approves Arcutis’ ZORYVE® (roflumila... Source: Arcutis Biotherapeutics, Inc.

Jun 23, 2026 @ 11:15 PM Arcutis Director Sells $121,000 in Stock as ZORYVE... Source: Jonathan Ponciano

Jun 9, 2026 @ 11:00 AM Antag Therapeutics Elects Keith Leonard as Chairma... Source: Not Specified

Jun 5, 2026 @ 8:00 PM Arcutis Biotherapeutics Reports Inducement Grants ... Source: Na

May 26, 2026 @ 8:00 PM Arcutis Management to Present at Goldman Sachs 47t... Source: Na

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.03	$-.09	$.13
Diluted EPS	$-.03	$-.09	$.13
Revenue	$415.62M	$105.4M	$129.5M
Gross Profit	$377.98M	$95.61M	$117.82M
Net Income / Loss	$-2.38M	$-11.3M	$17.4M
Operating Income / Loss	$3.21M	$-9.09M	$18.39M
Cost of Revenue	$37.65M	$9.78M	$11.69M
Net Cash Flow	$-18.7M	$-8.03M	$-4.27M
PE Ratio